In this study, using bioinformatics analysis of different public databases (including mRNA and miRNA sequencing data) combined with experimental assays, we confirmed that the transmembrane protein TMEM170B, is a novel direct target of miR-27a, and that it is significantly downregulated in breast cancer. This evidence concerns the gene TMEM170B and breast cancer.